AGLE – Aeglea BioTherapeutics, Inc.
AGLE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.96
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
8.43
EPS Last/This Y
19.42
EPS This/Next Y
0.33
Price
12.01
Target Price
17.5
Analyst Recom
2
Performance Q
-9.58
Upside
N/A
Beta
2.46
Ticker: AGLE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-23 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-04-24 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-04-27 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-04-28 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-04-29 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-04-30 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-01 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-04 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-05 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-06 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-07 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-08 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-11 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-12 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-13 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-14 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-15 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-18 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-19 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-20 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-21 | AGLE | 12.01 | N/A | N/A | 0 |
| 2026-05-22 | AGLE | 12.01 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
No data found
No data found
Last Quarter Act. EPS
-9.34
Avg. EPS Est. Current Quarter
-0.91
Avg. EPS Est. Next Quarter
-0.58
Insider Transactions
Institutional Transactions
-60.95
Beta
2.46
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
38
Growth Score
35
Sentiment Score
60
Actual DrawDown %
95.8
Max Drawdown 5-Year %
-99
Target Price
17.5
P/E
Forward P/E
PEG
P/S
46.32
P/B
P/Free Cash Flow
EPS
-78.22
Average EPS Est. Cur. Y
-5.33
EPS Next Y. (Est.)
-1.84
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-27934.72
Relative Volume
0.96
Return on Equity vs Sector %
96.2
Return on Equity vs Industry %
77.2
EPS 1 7Days Diff
EPS 1 30Days Diff
1.72
EBIT Estimation
No data found for AGLE
AGLE
Latest News
—
Caricamento notizie per AGLE…
stock quote shares AGLE – Aeglea BioTherapeutics, Inc. Stock Price stock today
news today AGLE – Aeglea BioTherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AGLE – Aeglea BioTherapeutics, Inc. yahoo finance google finance
stock history AGLE – Aeglea BioTherapeutics, Inc. invest stock market
stock prices AGLE premarket after hours
ticker AGLE fair value insiders trading